alexa Synthesis Of Novel Coumarin Derivatives And Its Nanoformulation For Enhanced Anticancer Activity | 66035
ISSN: 2167-0870

Journal of Clinical Trials
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

6th World Pharmacists and Clinical Pharmacy Annual Congress

Venkata Sairam Koganti, Gurupadayya BM, Vishwanathan B Iyer and Chandan R S
JSS University, India
ScientificTracks Abstracts: J Clin Trials
DOI: 10.4172/2167-0870-C1-013
Abstract
A series of coumarin derivatives were designed, synthesized, and evaluated for antioxidant and cytotoxic properties. The title compounds, 2-(3-substituted-4-methyl-2-oxo-2H-chromen-7-yloxy)-2-methylpropanoic acid derivatives; 5a-5f were synthesized by base catalyzed dehydrohalogenative cyclization following Hantzsch synthesis. All the newly synthesized analogues were characterized and established on the basis of mass, 1H NMR 13C NMR and IR studies. The compounds were evaluated for in vitro antioxidant activity and found to exhibit substantial activity. The in vitro cytotoxicity was evaluated against MCF-7, MDA-231 (human breast cancer) and HT29 (human colon adenocarcinoma) cell lines by MTT assay and the results were encouraging. Compound 5b, with a lower IC50 value of 2.4 and 4.8 μM for MCF-7 and MDA-231 respectively was considered to be potent among the series and exhibited selectivity towards the cancerous cell line; as a value addition, tumor targeting delivery of compound 5b to enhance its anticancer efficacy. Sodium alginate-chitosan nanoparticles were further prepared and loaded with the lead synthetic compound 5b. The delivery of 5b by tumor targeting nanoparticles resulted in significantly four fold decrease in the IC50 values in the tested MCF-7 breast cancer cell lines in comparison with free 5b tested. The major therapeutic drawback of anticancer agents towards non-selectivity and safety has also been addressed by formulating into pH selective nanogels of the newly synthesized coumarin molecules.
Biography

Venkata Sairam Koganti is currently a Doctoral Research student of Pharmaceutical Sciences at JSS University, JSS College of Pharmacy, India. He has completed his graduation from Rajiv Gandhi University of Health Sciences, Bangalore and Post-graduation from JSS University, India. His main area of research interests lies in the field of synthetic and analytical chemistry and nanoformulations. He has published widely in international journals and conferences.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

agr[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7